Screener
CorMedix CRMD EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from CorMedix’s reported figures.
Based on trailing twelve months.
The source filing: CorMedix’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
FAQ
- What is CorMedix's EBITDA margin?
- CorMedix (CRMD) reported EBITDA margin of 54.6% in Q1 2026.
- What is the long-term trend for CorMedix's EBITDA margin?
- Over 3 years (2020 to 2025), CorMedix's EBITDA margin has grown at a -83.3% compound annual growth rate (CAGR), from -11,324.9% to 52.8%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about CorMedix's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude